Melinda R. Roberts, a Member at Mintz, is a patent litigator who represents pharmaceutical and life sciences companies in ...

We have had great success in building a life sciences patent litigation team with the depth and range to handle our clients’ ...

NEW YORK — Mintz welcomes Melinda Roberts as a Member in the firm’s Intellectual Property Practice in New York, continuing the firm’s strategic growth in life sciences and patent litigation. Melinda ...

Mintz represented Delta Associated Investigations, a tech-enabled national provider of investigative and claims support ...

On July 14, 2026, the Federal Trade Commission (FTC) announced its settlement with Caremark Rx, LLC and Zinc Health Services, LLC (Caremark) to resolve claims from the FTC’s 2024 Complaint alleging ...

The Inflation Reduction Act (IRA) continues to reshape the US drug‑pricing landscape as federal implementation accelerates and market responses evolve. In 2025, regulators advanced core IRA programs ...

Artificial intelligence (AI) has emerged as an influential technology, driving notable investments across various industries in recent years. In 2024, venture capital (VC) funding for AI companies ...

The 2027 business immigration outlook for employers combines new restrictions with legal uncertainty. Automatic Employment Authorization Document (EAD) extensions are ending and visa processing is ...

On July 4, 2025, President Trump signed the One Big Beautiful Bill Act (OBBBA) into law, marking a significant turn in US clean energy policy. The new law dismantles or narrows many of the clean ...

Mintz represented the US Department of Energy in the closing of two separate loans totaling up to approximately $5.1 billion ...

Michael Renaud, Chair of Mintz’s Intellectual Property Division, has been named to IAM Global Leaders 2027, a guide ...